Teneligliptin
- CAS No.
- 760937-92-6
- Chemical Name:
- Teneligliptin
- Synonyms
- Teliglietin;teneligliptin;Teneligptin WS;Teneligliptin HB;Teneligliptin (MP-513);API (Teneligliptin free base);Teneligliptin, DPP-4 inhibitor;3-[[(2S,4R)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]thiazolidine;3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]thiazolidine;Methanone,[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-
- CBNumber:
- CB11518541
- Molecular Formula:
- C22H30N6OS
- Molecular Weight:
- 426.58
- MDL Number:
- MFCD13195565
- MOL File:
- 760937-92-6.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Teneligliptin | TRC-T018295-50MG | 50mg | $182 |
| Teneligliptin | TRC-T018295-25MG | 25mg | $122 |
| Teneligliptin | FT150538 | 0.5g | $900 |
| Teneligliptin | FT150538 | 0.25g | $900 |
| Teneligliptin | FT150538 | 0.1g | $900 |
| More product size | |||
| Melting point | >100°C (dec.) |
|---|---|
| Boiling point | 663.4±55.0 °C(Predicted) |
| Density | 1.38 |
| storage temp. | Refrigerator |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 8.70±0.10(Predicted) |
| color | Off-White |
| InChIKey | WGRQANOPCQRCME-PMACEKPBSA-N |
| SMILES | C([C@@H]1C[C@H](N2CCN(C3N(C4=CC=CC=C4)N=C(C)C=3)CC2)CN1)(N1CCSC1)=O |
| FDA UNII | 28ZHI4CF9C |
| ATC code | A10BH08 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362 |
Teneligliptin price More Price(45)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| TRC | TRC-T018295-50MG | Teneligliptin | 760937-92-6 | 50mg | $182 | 2026-06-03 | Buy |
| TRC | TRC-T018295-25MG | Teneligliptin | 760937-92-6 | 25mg | $122 | 2026-06-03 | Buy |
| Biosynth | FT150538 | Teneligliptin | 760937-92-6 | 0.5g | $900 | 2026-06-04 | Buy |
| Biosynth | FT150538 | Teneligliptin | 760937-92-6 | 0.25g | $900 | 2026-06-04 | Buy |
| Biosynth | FT150538 | Teneligliptin | 760937-92-6 | 0.1g | $900 | 2026-06-04 | Buy |
Teneligliptin Chemical Properties,Uses,Production
Description
Teneligliptin was approved in September 2012 in Japan for the treatment of patients with Type 2 diabetes mellitus (T2DM). Teneligliptin is a member of the dipeptidyl peptidase 4 (DPP-4) inhibitor class of antidiabetes agents. DPP-4 is an enzyme that degrades GLP-1, a 30-amino acid peptide that is secreted in response to food intake. GLP-1 stimulates insulin secretion and inhibits glucagon secretion, which leads to lower levels of plasma glucose. Teneligliptin is one of a growing numbers of DPP-4 inhibitors to be approved worldwide. The discovery of teneligliptin was guided by structure-based design, with a key element being binding of the phenyl group in the S2 pocket, which not only increases potency for DPP-4, but also improves selectivity versus DPP-8 and DPP- 9. Teneligliptin is a potent inhibitor of DPP-4 in the enzyme inhibition assay (IC50=0.37 nM).
Originator
Mitsubishi Tanabe Pharma (Japan)
Uses
Teneligliptin, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion, and has a half-life of 24.2 hours in the human body.
Definition
ChEBI: Teneligliptin is an amino acid amide.
brand name
Tenelia
Pharmacokinetics
Reported evidence suggests that with teneligliptin 20 mg therapy, Tmax was 1 hour, and t1/2 was 18.9 hours. Maximum (89.7%) inhibition in plasma DPP-4 activity was noted within 2 hours and maintained >60% at 24 hours. Compared to the placebo, active plasma GLP-1 concentration was higher throughout the day and even 24 hours after administration of 20 mg of teneligliptin. Metabolism of teneligliptin was majorly mediated through CYP3A4, a cytochrome P450 isozyme, and flavin-containing monooxygenases (FMO1 and FMO3). A weak inhibitory activity of teneligliptin on CYP2D6, CYP3A4, and FMO was noted, while there was no inhibitory activity on CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C8/9, CYP2C19, and CYP2E1. There was no induction of expression of CYP1A2 or CYP3A4. Reported evidence suggests that teneligliptin is metabolized and eliminated via renal and hepatic routes. Approximately 34% of teneligliptin is excreted unchanged via the renal route, while 66% is metabolized and eliminated via the hepatic and renal routes[1].
Side effects
The DPP-4 molecule in teneligliptin reduces the risk of hypoglycemia, although it is possible. These are some of teneligliptin’s major and minor side effects:
Hypoglycemia
Headache
Upper respiratory tract infection
Gastrointestinal symptoms
Constipation
Fatigue
Kidney problems
Nasopharyngitis
Skin rashes
Itching
Loss of appetite
Abdominal pain
References
[1] Surendra Kumar Sharma. “Teneligliptin in management of type 2 diabetes mellitus.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 9 (2016): 251–60.


Teneligliptin Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ChemExpress | +86-19370970350 +86-021-58950125 | info@chemexpress.com | China | 790 | 58 |
| Capot Chemical Co.,Ltd. | +86-(0)57185586718 +86-13336195806 | sales@capot.com | China | 29626 | 60 |
| Shanghai Daken Advanced Materials Co.,Ltd | +86-2158073036 | info@dakenam.com | China | 14034 | 58 |
| Anqing Chico Pharmaceutical Co., Ltd. | 15380796838 | chloewu@chicopharm.cn | CHINA | 340 | 58 |
| career henan chemical co | +86-0371-86658258 | sales@coreychem.com | China | 29766 | 58 |
| CONIER CHEM AND PHARMA LIMITED | sales@conier.com | China | 49906 | 58 | |
| ANHUI WITOP BIOTECH CO., LTD | +8618071025641 | eric@witopchemical.com | China | 23504 | 58 |
| Xi'an MC Biotech, Co., Ltd. | 029-89275612 +8618991951683 | mcbio_sales@163.com | China | 2240 | 58 |
| Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1059@dideu.com | China | 29096 | 58 |
| AFINE CHEMICALS LIMITED | +86-571-85134551 +86-18958018566 | info@afinechem.com | China | 15058 | 58 |
Related articles
- Teneligliptin: Indications, Mechanism of Action and Side Effects
- Teneligliptin is a novel third-generation DPP-4 inhibitor approved for the treatment of type II diabetes. The compound has a u....
- Dec 16,2024
View Lastest Price from Teneligliptin manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | Teneligliptin
760937-92-6
|
$30.00-40.00 | 99.83% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-04-04 | Teneligliptin
760937-92-6
|
1KG | 98% | 1ton | Henan Aochuang Chemical Co.,Ltd. | ||
![]() |
2024-11-26 | Teneligliptin
760937-92-6
|
1kg | 99%, Single impurity<0.1 | 1 ton | Nanjing Fred Technology Co., Ltd |
-

- Teneligliptin
760937-92-6
- $30.00-40.00
- 99.83%
- TargetMol Chemicals Inc.
-

- Teneligliptin
760937-92-6
- 98%
- Henan Aochuang Chemical Co.,Ltd.
-

- Teneligliptin
760937-92-6
- 99%, Single impurity<0.1
- Nanjing Fred Technology Co., Ltd





